A new study led by Boston Medical Center uncovered a need to improve testing rates for Hepatitis C Virus (HCV) in young people, specifically those with documented substance use history. In the national data sample, under ...
Dec 10, 2019
0
2
Hepatitis C is a serious disease, but the biggest threat to someone's health is not the virus itself. Rather, it is the diseases that can result from it such as reduced liver functioning, scar tissue in the liver and potentially ...
Dec 05, 2019
0
2
A multicomponent intervention can improve hepatitis C virus (HCV) screening, although there is considerable variation by practice, according to a study published online Dec. 3 in the Annals of Internal Medicine.
Dec 03, 2019
0
2
(HealthDay)—End-stage renal disease (ESRD) patients are at a higher risk for contracting syphilis, according to a study recently published in the Clinical Kidney Journal.
Dec 02, 2019
0
0
A discovery about how the immune system responds to malaria infection could lead to better treatments for hepatitis C, HIV and lupus, say Australian researchers.
Nov 19, 2019
0
818
In Canada, 171,900 people injected drugs in 2016, up from 130,000 in 2011. In a study published in the American Journal of Public Health, researchers at the University of Montreal Hospital Research Centre (CRCHUM) estimated, ...
Nov 14, 2019
0
2
Viral hepatitis is a disease that causes inflammation of the liver. There are three viruses responsible for most cases of the disease: hepatitis A, B, and C. Hepatitis A is typically caused by consuming contaminated food ...
Nov 11, 2019
0
4
Hepatitis B is blood-borne virus that packs a punch. Worldwide, more than 1.3 billion people have been infected with hepatitis B, and 257 million people have developed a life-long infection. This includes 240,000 Australians, ...
Oct 24, 2019
0
2
Organs from potential donors once rejected as being unsafe to transplant may not be as risky as once thought, new Australian research shows.
Oct 14, 2019
0
4
An alarming number of people nationwide are developing infections of either the heart's inner lining or valves, known as infective endocarditis, in large part, due to the current opioid epidemic. This new trend predominantly ...
Sep 18, 2019
0
11
Hepatitis C is an infectious disease affecting the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but once established, chronic infection can progress to scarring of the liver (fibrosis), and advanced scarring (cirrhosis) which is generally apparent after many years. In some cases, those with cirrhosis will go on to develop liver failure or other complications of cirrhosis, including liver cancer.
The hepatitis C virus (HCV) is spread by blood-to-blood contact. Most people have few, if any symptoms after the initial infection, yet the virus persists in the liver in about 85% of those infected. Persistent infection can be treated with medication, peginterferon and ribavirin being the standard-of-care therapy. Only 51% are cured overall. Those who develop cirrhosis or liver cancer may require a liver transplant, and the virus universally recurs after transplantation.
An estimated 270-300 million people worldwide are infected with hepatitis C. Hepatitis C is a strictly human disease. It cannot be contracted from or given to any animal. Chimpanzees can be infected with the virus in the laboratory, but do not develop the disease, which has made research more difficult. No vaccine against hepatitis C is available. The existence of hepatitis C (originally "non-A non-B hepatitis") was postulated in the 1970s and proved conclusively in 1989. It is one of five known hepatitis viruses: A, B, C, D, and E.
This text uses material from Wikipedia, licensed under CC BY-SA
